Education
About Us
Working with TipRanks
Follow Us
OncoTherapy Science, Inc. (JP:4564)
:4564
RESEARCH TOOLSreports
4564 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥21.00 - ¥64.00
Previous CloseN/A
Volume4.29M
Average Volume (3M)10.08M
Market Cap
¥8.83B
Enterprise Value¥7.59B
Total Cash (Recent Filing)¥945.00M
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Aug 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.16
Shares Outstanding304,643,700
10 Day Avg. Volume8,925,550
30 Day Avg. Volume10,078,780
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)10.80
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥22.40Price Target Upside-17.03% Downside
Rating ConsensusHold
Number of Analyst Covering0
4564 FAQ
What was OncoTherapy Science, Inc.’s price range in the past 12 months?
OncoTherapy Science, Inc. lowest stock price was ¥21.00 and its highest was ¥64.00 in the past 12 months.
What is OncoTherapy Science, Inc.’s market cap?
OncoTherapy Science, Inc.’s market cap is ¥8.83B.
When is OncoTherapy Science, Inc.’s upcoming earnings report date?
OncoTherapy Science, Inc.’s upcoming earnings report date is Aug 01, 2025 which is in 5 days.
How were OncoTherapy Science, Inc.’s earnings last quarter?
OncoTherapy Science, Inc. released its earnings results on Feb 07, 2025. The company reported -¥0.6 earnings per share for the quarter, missing the consensus estimate of N/A by -¥0.6.
Is OncoTherapy Science, Inc. overvalued?
According to Wall Street analysts OncoTherapy Science, Inc.’s price is currently Overvalued.
Does OncoTherapy Science, Inc. pay dividends?
OncoTherapy Science, Inc. does not currently pay dividends.
What is OncoTherapy Science, Inc.’s EPS estimate?
OncoTherapy Science, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OncoTherapy Science, Inc. have?
OncoTherapy Science, Inc. has 304,643,700 shares outstanding.
What happened to OncoTherapy Science, Inc.’s price movement after its last earnings report?
OncoTherapy Science, Inc. reported an EPS of -¥0.6 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of OncoTherapy Science, Inc.?
Currently, no hedge funds are holding shares in JP:4564
Company Description
OncoTherapy Science, Inc.
OncoTherapy Science (4564) is a biotechnology company based in Japan that focuses on the research and development of novel cancer therapies. The company is primarily involved in the discovery and development of cancer-targeted drugs, including therapeutic cancer vaccines, monoclonal antibodies, and small molecule drugs. OncoTherapy Science aims to address unmet medical needs in oncology through innovative treatment options.
Technical Analysis
Chiome Bioscience Inc.
―
Oncolys BioPharma, Inc.
―
Healios KK
―
Delta-Fly Pharma, Inc.
―
FunPep Company Limited
―